)
Edge28 Nov 2025
Keeping the Streak Alive: The Story of Duolingo
How Duolingo made language learning addictive, scaled to millions of users, and built a powerful subscription business around everyday practice.
Oncopeptides (ONCO) investor relations material
Oncopeptides CMD 2025 summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.CMD 2025 summary13 Nov, 2025
Current business performance and market position
Achieved SEK 20 million in Q3 2025 sales, marking 174% year-over-year growth and four consecutive quarters of European commercialization growth.
Pepaxti is now available in key European markets (Germany, Austria, Spain, Italy), with profitability targeted by end of 2026.
Over 550 patients treated across Europe, with positive clinical experience and inclusion in European guidelines.
Strategic partnerships are expanding access to new geographies, including South Korea, MENA, and ongoing late-stage due diligence for Japan.
Real-world data and clinical endorsements are driving broader adoption and market confidence.
Product innovation and clinical differentiation
Pepaxti (melflufen) is the first peptide drug conjugate from the platform, offering a unique, immune-independent mechanism of action.
Demonstrates efficacy in triple-class refractory multiple myeloma, including high-risk and elderly patients, and is suitable as bridging therapy before immunotherapies.
Once-monthly IV administration supports patient quality of life and logistical flexibility.
Safety profile is favorable, with manageable hematologic toxicity and minimal non-hematologic side effects.
Real-world and clinical trial data confirm durable benefit, manageable toxicity, and broad applicability across patient subgroups.
Strategic pipeline and future growth opportunities
Pipeline includes next-generation PDCs (OPD5, OPDC3) and the SPiKEs platform for NK cell engagement, targeting oncology, hematology, and autoimmune diseases.
OPD5 shows promise in combination regimens and glioblastoma, with strong preclinical data and blood-brain barrier penetration.
SPiKEs platform offers differentiated, tolerable immunotherapy options for both cancer and autoimmune indications, with unique BCMA targeting.
Preclinical progress is advancing assets toward IND readiness, with a focus on scalable manufacturing and strategic partnerships for clinical development.
The company is leveraging grants, collaborations, and licensing deals to support pipeline advancement and global expansion.
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Next Oncopeptides earnings date
Q4 202519 Feb, 2026
Next Oncopeptides earnings date
Q4 202519 Feb, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Oncopeptides AB, a biotech company, focuses on the development of therapies for patients with cancer. The company's lead drug candidate is melflufen, which has received orphan drug designation from the European Commission, as well as from the FDA for the treatment of multiple myeloma. Its product pipeline also comprises peptide-drug conjugates that are in preclinical stage development for hematological malignancies and solid tumors. The company is based in Stockholm, Sweden
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage